National Bank of Canada’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6 | Sell |
1
-240
| -100% | -$1.44K | ﹤0.01% | 2591 |
|
2025
Q1 | $1.17K | Hold |
241
| – | – | ﹤0.01% | 2236 |
|
2024
Q4 | $2.3K | Sell |
241
-957
| -80% | -$9.15K | ﹤0.01% | 2191 |
|
2024
Q3 | $10K | Buy |
1,198
+1,141
| +2,002% | +$9.53K | ﹤0.01% | 1897 |
|
2024
Q2 | $403 | Hold |
57
| – | – | ﹤0.01% | 2422 |
|
2024
Q1 | $247 | Hold |
57
| – | – | ﹤0.01% | 2435 |
|
2023
Q4 | $147 | Hold |
57
| – | – | ﹤0.01% | 2464 |
|
2023
Q3 | $180 | Hold |
57
| – | – | ﹤0.01% | 2475 |
|
2023
Q2 | $418 | Sell |
57
-96
| -63% | -$704 | ﹤0.01% | 2456 |
|
2023
Q1 | $1.58K | Hold |
153
| – | – | ﹤0.01% | 2334 |
|
2022
Q4 | $1.8K | Hold |
153
| – | – | ﹤0.01% | 2334 |
|
2022
Q3 | $3K | Hold |
153
| – | – | ﹤0.01% | 2257 |
|
2022
Q2 | $5K | Hold |
153
| – | – | ﹤0.01% | 2211 |
|
2022
Q1 | $6K | Hold |
153
| – | – | ﹤0.01% | 2264 |
|
2021
Q4 | $7K | Buy |
+153
| New | +$7K | ﹤0.01% | 2224 |
|